drugset / Trial / NCT04890704

Curcuminoids and Contrast-induced Acute Kidney Injury

NCT04890704

RandomizedParallel-groupSingle-blindPrevention

Summary

The objective of this study was to evaluate the role of curcuminoids in the prevention of CI-AKI in CKD patients.The result of the study was prophylactic administration with curcuminoids in addition to standard treatment reduce the incidence of CI-AKI CKD patients undergoing elective CAG.

Timeline

Start
2018-10-01
Primary completion
2019-03-31
Completion
2019-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcuminoids Traditional medicine (herbal / TCM) 500 mg